100 Wistar rats were randomly divided into 5
groups: control group (CON3), control plus STZ injection group (C-STZ), high-fat
diet group (HFD), high-fat diet plus STZ injection group (HFD-STZ), Berberine treated
high-fat diet plus STZ injection group (BER); control group and control plus
STZ injection group were fed with regular chow, and other three groups were
given high-fat diet for 4 weeks; the C-STZ, HFD-STZ groups and BER group were
injected IP with a low dose of STZ (according to the second section, choosing
the dose of the group with higher
successful rate: 30 mg/kg). After one week, FBG was measured in these three
groups, the rats with FBG < 7.8 mmol/L were injected with STZ again (30 mg/kg), while the control rats were
given vehicle citrate buffer (pH 4.4) in a dose volume of 0.25 mL/kg, IP,
respectively. The fasting blood glucose was measured every week. After 4 weeks of
STZ injection, the rats with the fasting blood glucose of ≥7.8 mmol/L twice or with nonfasting blood glucose of ≥11.1 mmol/L were considered diabetic. Berberine (100 mg/kg body weight) was
administered orally as suspension by mixing with vehicle 1% Na-CMC at a dose
volume of 0.5 mL/kg body weight of rats in treatment group for another 4 weeks.
The body weight and food intake of the animals were also measured. The rats were
allowed to continue to feed on their respective diets until the end of the
study. At the end of the study, IPGTT and ITT were conducted in the five groups;
fasting plasma was collected for further measurement of insulin, TG, TC, and
glucose. The insulin sensitivity index (ISI) was calculated according to the fasting insulin and glucose
concentration.
groups: control group (CON3), control plus STZ injection group (C-STZ), high-fat
diet group (HFD), high-fat diet plus STZ injection group (HFD-STZ), Berberine treated
high-fat diet plus STZ injection group (BER); control group and control plus
STZ injection group were fed with regular chow, and other three groups were
given high-fat diet for 4 weeks; the C-STZ, HFD-STZ groups and BER group were
injected IP with a low dose of STZ (according to the second section, choosing
the dose of the group with higher
successful rate: 30 mg/kg). After one week, FBG was measured in these three
groups, the rats with FBG < 7.8 mmol/L were injected with STZ again (30 mg/kg), while the control rats were
given vehicle citrate buffer (pH 4.4) in a dose volume of 0.25 mL/kg, IP,
respectively. The fasting blood glucose was measured every week. After 4 weeks of
STZ injection, the rats with the fasting blood glucose of ≥7.8 mmol/L twice or with nonfasting blood glucose of ≥11.1 mmol/L were considered diabetic. Berberine (100 mg/kg body weight) was
administered orally as suspension by mixing with vehicle 1% Na-CMC at a dose
volume of 0.5 mL/kg body weight of rats in treatment group for another 4 weeks.
The body weight and food intake of the animals were also measured. The rats were
allowed to continue to feed on their respective diets until the end of the
study. At the end of the study, IPGTT and ITT were conducted in the five groups;
fasting plasma was collected for further measurement of insulin, TG, TC, and
glucose. The insulin sensitivity index (ISI) was calculated according to the fasting insulin and glucose
concentration.
Full text: Click here